DUBLIN, April 21, 2015 /PRNewswire/ --
Third Quarter FY 2015 Highlights:
• Delivered record fiscal third quarter net sales of $1.05 billion.
• Excluding the effect of the pre-closing debt and equity issuances related to the Omega Pharma (Omega) acquisition, fiscal third quarter adjusted net income increased 41% to a third quarter record of $249 million, with adjusted diluted earnings per share of $1.85 also up 41%.
• Reported fiscal third quarter GAAP net loss of $95 million and GAAP diluted loss per share of $0.67 driven by Omega-related charges.
• Achieved record fiscal third quarter adjusted gross margin of 45.7% (GAAP gross margin of 36.1%) and record adjusted operating margin of 29.8% (GAAP operating margin of 19.0%).
• Generated record third quarter operating cash flow of $268 million.
Help employers find you! Check out all the jobs and post your resume.
Third Quarter FY 2015 Highlights:
• Delivered record fiscal third quarter net sales of $1.05 billion.
• Excluding the effect of the pre-closing debt and equity issuances related to the Omega Pharma (Omega) acquisition, fiscal third quarter adjusted net income increased 41% to a third quarter record of $249 million, with adjusted diluted earnings per share of $1.85 also up 41%.
• Reported fiscal third quarter GAAP net loss of $95 million and GAAP diluted loss per share of $0.67 driven by Omega-related charges.
• Achieved record fiscal third quarter adjusted gross margin of 45.7% (GAAP gross margin of 36.1%) and record adjusted operating margin of 29.8% (GAAP operating margin of 19.0%).
• Generated record third quarter operating cash flow of $268 million.
Help employers find you! Check out all the jobs and post your resume.
